4.0
Mar 21, 2017
Anonymous employee
Former employee
South San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Best drug developer in the world. Great minds and thorough strategic assessment of opportunities. Play in oncology and other specialty areas which allow for great ROI.
Cons
Gone but not forgotten. Current version of company is slowly evolving to become more like Roche. Loss of Ian is a big deal. Bill is not a suitable replacement.